There are 6 genotypes of the virus, with genotype 1
comprising approximately 75% of the HCV population in
the US. Unfortunately, genotype 1 infection is the most
difficult treat. Genotypes 2 and 3 are less common but
more responsive to traditional therapy with pegylated
interferon and ribavirin (PEG-IFN plus RBV)